Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Recent changes
Random page
Help about MediaWiki
Special pages
Surgopaedia
Search
Search
Appearance
Create account
Log in
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Editing
Thyroid cancer
(section)
Page
Discussion
English
Read
Edit
Edit source
View history
Tools
Tools
move to sidebar
hide
Actions
Read
Edit
Edit source
View history
General
What links here
Related changes
Page information
Appearance
move to sidebar
hide
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
=== '''Treatment''' === ** Neoadjuvant therapy *** Consider for those with significant burden of metastatic disease ** Clinically evident disease *** Must differentiate between sporadic and inherited from the start! **** If phaeo is also present, do adrenalectomy first **** If MEN2A is present check for PHPT and do a four-gland exploration simultaneously (enlarged parathyroids should be resected, even if eucalcaemic) **** If RET is positive, guidelines dictate when prophylactic thyroidectomy should take place based on genotype **** If MEN2B is present, prophylactic total thyroidectomy and bilateral central neck dissection should be performed <1yo *** '''Needs total thyroidectomy + bilateral central neck dissection''' even if N0. Lateral neck dissection performed for biopsy-proven lateral neck disease or high suspicion of lateral neck disease based on high serum calcitonin (number not really fixed, some say 250, some say 500, make an overall risk stratification). ** Offer prophylactic total thyroidectomy to those with RET *** Aim to do it before central neck dissection is required *** Timing depends largely on specific ''RET'' mutation ** Adjuvant therapy *** Traditional systemic chemotherapy is ineffective *** Tyrosine kinase receptor therapies can be useful - vandetanib *** EBRT to neck and mediastinum for those with incompletely resected or high risk tumours (although no benefit to overall survival)
Summary:
Please note that all contributions to Surgopaedia may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Surgopaedia:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Search
Search
Editing
Thyroid cancer
(section)
Add topic